The MarginGuide: a medical device to improve the results of cancer surgery

Project description

Better outcomes for oral cancers thanks to high-tech tumour boundary identification

Complete removal of oral tumours is rare because the tumour boundary is determined by hand and eye, resulting in overly cautious estimations. This often leads to more surgery or tumour therapy and negatively impacts the patient’s prognosis. The Netherlands-based SME SurGuide has developed a novel device based on Raman spectroscopy to discriminate cancerous from healthy tissue in the resected tumour. If a margin of more than five millimetres of healthy tissue is not present (the criteria for adequate tumour resection), additional removal is warranted. The EU-funded MarginGuide project is supporting a technical and business feasibility study that should lead to a successful commercialisation plan.

Fields of science

• medical and health sciences › clinical medicine › surgery
• medical and health sciences › clinical medicine › oncology
• natural sciences › physical sciences › optics › spectroscopy

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

SURGUIDE BV

Net EU contribution

€ 50 000,00

Address

Marconistraat 16
3029 AK Rotterdam
Netherlands

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 21 429,00